Thomas Malley Insider Profile

4 Followers
Thomas Malley, Director at Puma Biotechnology, holds 81.34K shares in Kiniksa Pharmaceuticals (Ticker: KNSA), holds 139.56K shares in Kura Oncology (Ticker: KURA), holds 76.70K shares in BeiGene (Ticker: BGNE).
tipranks
Thomas Malley

Thomas Malley
Puma Biotechnology (PBYI)
Director

Ranked #16,008 out of 99,218 Corporate Insiders

Profitable Transactions

50%
2 out of 4 Profitable Transactions

Average Return

+31.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$21M
76.23%
11.94%
8.99%
2.18%
0.66% Others
A breakdown of Thomas Malley's holdings

Insider Roles

BeiGene
(BGNE)
Director
Kura Oncology
(KURA)
Director
Kiniksa Pharmaceuticals
(KNSA)
Director
Puma Biotechnology
(PBYI)
Director
+1 other positions
Roles that Thomas Malley holds in companies

Most Profitable Insider Trade

Stock:
BeiGene
(BGNE)
Rating:Informative Buy
Date:Nov 28, 2016 - Nov 28, 2017
Return:+182.00%
The most profitable trade made by Thomas Malley

Thomas Malley's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Puma Biotechnology
Oct 25, 2012
Director
Informative Buy
160.00K
$450.87K
BeiGene
Jun 20, 2023
Director
Uninformative Buy
$15.76M
Kura Oncology
Jun 21, 2023
Director
Informative Buy
575.00K
$2.47M
Kiniksa Pharmaceuticals
Jun 07, 2024
Director
Uninformative Buy
85.36K
$1.86M
Tempest Therapeutics
Jul 05, 2017
Director
Uninformative Buy
$136.88K
GEVA
Synageva
Jun 23, 2015
Uninformative Sell
List of latest transactions for each holding click on a transaction to see Thomas Malley's performance on stock

Thomas Malley insider profile FAQ

What is the percentage of profitable transactions made by Thomas Malley?
The percentage of profitable transactions made by Thomas Malley is 50%.
    What is the average return per transaction made by Thomas Malley?
    The average return per transaction made by Thomas Malley is 31.00%.
      What stocks does Thomas Malley hold?
      Thomas Malley holds: PBYI, BGNE, KURA, KNSA, TPST, GEVA stocks.
        What was Thomas Malley’s latest transaction?
        Thomas Malley latest transaction was an Uninformative Buy of $85.36K.
          What was Thomas Malley's most profitable transaction?
          Thomas Malley’s most profitable transaction was an Informative Buy of BGNE stock on November 28, 2016. The return on the trade was 182.00%.
            What is Thomas Malley's role in Puma Biotechnology?
            Thomas Malley's role in Puma Biotechnology is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.